Page last updated: 2024-08-24

cephalosporin c and malondialdehyde

cephalosporin c has been researched along with malondialdehyde in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19901 (11.11)18.7374
1990's4 (44.44)18.2507
2000's4 (44.44)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cojocel, C1
Baumann, K; Cojocel, C; Göttsche, U; Tölle, KL1
Dionyssiou-Asteriou, A; Giamarellos-Bourboulis, EJ; Giamarellou, H; Grecka, P1
Owada, S; Yokozawa, T1
Mykhaĭlovych, IuI1
Dionyssiou-Asteriou, A; Dontas, I; Giamarellos-Bourboulis, EJ; Giamarellou, H; Karayannacos, PE; Plachouras, D; Raftogiannis, M; Skiathitis, S1
Baumann, K; Cojocel, C; El-Hajj, H; Tolle, KL1
Chaudhary, M; Dwivedi, VK; Soni, A1
Chaudhary, M; Dwivedi, VK; Shrivastava, SM; Singh, CP; Soni, A1

Other Studies

9 other study(ies) available for cephalosporin c and malondialdehyde

ArticleYear
Biochemical aspects of the renal tolerance for cefpirome and other cephalosporins.
    Arzneimittel-Forschung, 1990, Volume: 40, Issue:10

    Topics: Animals; Cefotaxime; Cefpirome; Cephalosporins; Cytosol; Gluconeogenesis; Glutathione; In Vitro Techniques; Kidney Cortex; Kidney Diseases; L-Lactate Dehydrogenase; Male; Malondialdehyde; Oxidation-Reduction; Rats; Rats, Inbred Strains; Tetraethylammonium; Tetraethylammonium Compounds

1990
Nephrotoxic potential of first-, second-, and third-generation cephalosporins.
    Archives of toxicology, 1988, Volume: 62, Issue:6

    Topics: Animals; Cephalosporins; Gluconeogenesis; Kidney Diseases; Lipid Peroxides; Male; Malondialdehyde; Rats; Rats, Inbred Strains; Tetraethylammonium Compounds

1988
In vitro activity of polyunsaturated fatty acids on Pseudomonas aeruginosa: relationship to lipid peroxidation.
    Prostaglandins, leukotrienes, and essential fatty acids, 1998, Volume: 58, Issue:4

    Topics: Amikacin; Ampicillin Resistance; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporin Resistance; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Drug Resistance, Multiple; Fatty Acids, Unsaturated; gamma-Linolenic Acid; Gentamicins; Imipenem; Lipid Peroxidation; Malondialdehyde; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Species Specificity; Thienamycins; Ticarcillin; Tobramycin; Vitamin E

1998
Effect of ginsenoside-Rd in cephaloridine-induced renal disorder.
    Nephron, 1999, Volume: 81, Issue:2

    Topics: Animals; Blood Urea Nitrogen; Catalase; Cephaloridine; Cephalosporins; Creatinine; Ginsenosides; Glycosuria; Hypolipidemic Agents; Kidney Diseases; Kidney Tubules, Proximal; L-Lactate Dehydrogenase; Lipid Peroxidation; LLC-PK1 Cells; Male; Malondialdehyde; Potassium; Rats; Rats, Wistar; Reactive Oxygen Species; Saponins; Sodium; Superoxide Dismutase; Swine

1999
[The effect of the regimen for administering antibacterial therapy on the manifestations of endogenous intoxication in patients operated on for lung cancer].
    Likars'ka sprava, 1999, Issue:6

    Topics: Antibiotic Prophylaxis; Biomarkers; Cefotaxime; Cephalosporins; Humans; Lung Neoplasms; Malondialdehyde; Postoperative Care; Preoperative Care; Retrospective Studies; Sepsis; Superoxide Dismutase; Time Factors

1999
Ex vivo synergy of arachidonate-enriched serum with ceftazidime and amikacin on multidrug-resistant Pseudomonas aeruginosa.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:2

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Arachidonic Acid; Ceftazidime; Cephalosporins; Colony Count, Microbial; Culture Media; Drug Resistance, Multiple, Bacterial; Drug Synergism; Lipid Peroxides; Male; Malondialdehyde; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Rabbits; Thiobarbituric Acid Reactive Substances; Time Factors

2003
Protection against cephalosporin-induced lipid peroxidation and nephrotoxicity by (+)-cyanidanol-3 and vitamin E.
    Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas, 2007, Volume: 40, Issue:6

    Topics: Animals; Anti-Bacterial Agents; Antioxidants; Catechin; Cephalosporins; Glutathione; Kidney Cortex; Kidney Function Tests; Lipid Peroxidation; Liver; Male; Malondialdehyde; Rats; Rats, Wistar; Vitamin E

2007
Fixed dose combination of cefepime plus amikacin prevent oxidative stress in liver of Mus musculus mice.
    Current clinical pharmacology, 2008, Volume: 3, Issue:3

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Antioxidants; Catalase; Cefepime; Cephalosporins; Drug Combinations; Lipid Peroxidation; Liver; Malondialdehyde; Mice; Oxidative Stress; Superoxide Dismutase

2008
Fixed-dose combination of cefepime plus amikacin (potentox) inhibits pneumonia infection.
    Experimental lung research, 2009, Volume: 35, Issue:7

    Topics: Amikacin; Animals; Anti-Bacterial Agents; Antioxidants; Catalase; Cefepime; Cephalosporins; Drug Therapy, Combination; Klebsiella Infections; Klebsiella pneumoniae; Lipid Peroxidation; Male; Malondialdehyde; Oxidative Stress; Pneumonia, Bacterial; Rats; Rats, Wistar; Superoxide Dismutase

2009